The Ionis link (with licensing and royalty agreement) only makes sense imo if ANP are linked to Ionis IP, or have a potential pipeline of new Ionis drugs/IP. The first will no longer exist after September and the second is highly dubious since we’ve had no new drugs licenced for umpteen years.
The Ionis agreement would have been an obstacle to partnership or takeover deals. The tox study box getting ticked and a possible end to the Ionis agreement appear to be like house improvements before one sells.
The share price is not behaving though. The worst scenario is a lowish MC, perhaps caused by inadequate funding issues getting worse, combined with the above two hypothetical positives (ignoring better combo data) and hey presto, some global DMD/Limb Girdle drug provider can pick us up for a song, even before P2b results.
I only muse though.
- Forums
- ASX - By Stock
- Ann: Chief Executive Officer and Managing Director Appointment
The Ionis link (with licensing and royalty agreement) only makes...
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.7¢ |
Change
0.003(3.57%) |
Mkt cap ! $78.43M |
Open | High | Low | Value | Volume |
8.4¢ | 8.7¢ | 8.4¢ | $72.99K | 855.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 452608 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 398595 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 452608 | 0.084 |
3 | 212500 | 0.083 |
2 | 106250 | 0.080 |
2 | 125578 | 0.079 |
1 | 12462 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 398595 | 1 |
0.088 | 400000 | 1 |
0.089 | 135000 | 2 |
0.090 | 794374 | 5 |
0.092 | 50000 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online